Volume 10, Issue 1 (2-2023)
JROS 2023, 10(1): 27-34 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Moghtadaei M, Yeganeh A, Amin Pirjeli S, Farahini H. Effect of Systemic Corticosteroids on Pain Control After Total Knee Arthroplasty. JROS 2023; 10 (1) :27-34
URL: http://jros.iums.ac.ir/article-1-2246-en.html
URL: http://jros.iums.ac.ir/article-1-2246-en.html
1- Department of Orthopedics, School of Medicine, Bone and Joint Reconstruction Research Center, Iran University of Medical Sciences, Tehran, Iran.
Abstract: (95 Views)
Background: Reducing pain is the most important goal of total knee arthroplasty (TKA).
Objectives: The present study aimed to evaluate the effect of systemic corticosteroids on pain control after TKA.
Methods: The present study was performed as a randomized controlled clinical trial study on 75 patients. Patients were randomly assigned to three groups (n=25): the dexamethasone (Dex) group received Dex 8 mg/IV at three times (24 mg), the Met group received methylprednisolone (Met)125 mg/IV, and the control group received isotonic fluid IV (placebo). Primary outcomes included knee nausea, vomiting, and pain 4, 12, and 24 hours after surgery. The pain was assessed using the visual analog scale. Also, patients’ performance indices were evaluated based on the Western Ontario and McMaster universities osteoarthritis (WOMAC) index after surgery.
Results: The mean scores of pain, 4, 12, and 24 h after surgery in the Dex and Met groups were significantly lower than the placebo group (P<0.001). The mean score of WOMAC and subscales in the Dex, Met, and placebo groups was not significantly different. Postoperative nausea was reduced significantly in the Dex group (P=0.002).
Conclusion: This study shows that administering 24 mg Dex or 125 mg Met significantly reduces pain and nausea 6, 12, and 24 hours after TKA. The effect of Met is significantly less than Dex in controlling pain and nausea. In contrast, Dex and Met had no impact on improvement based on the WOMAC index in patients after TKA.
Objectives: The present study aimed to evaluate the effect of systemic corticosteroids on pain control after TKA.
Methods: The present study was performed as a randomized controlled clinical trial study on 75 patients. Patients were randomly assigned to three groups (n=25): the dexamethasone (Dex) group received Dex 8 mg/IV at three times (24 mg), the Met group received methylprednisolone (Met)125 mg/IV, and the control group received isotonic fluid IV (placebo). Primary outcomes included knee nausea, vomiting, and pain 4, 12, and 24 hours after surgery. The pain was assessed using the visual analog scale. Also, patients’ performance indices were evaluated based on the Western Ontario and McMaster universities osteoarthritis (WOMAC) index after surgery.
Results: The mean scores of pain, 4, 12, and 24 h after surgery in the Dex and Met groups were significantly lower than the placebo group (P<0.001). The mean score of WOMAC and subscales in the Dex, Met, and placebo groups was not significantly different. Postoperative nausea was reduced significantly in the Dex group (P=0.002).
Conclusion: This study shows that administering 24 mg Dex or 125 mg Met significantly reduces pain and nausea 6, 12, and 24 hours after TKA. The effect of Met is significantly less than Dex in controlling pain and nausea. In contrast, Dex and Met had no impact on improvement based on the WOMAC index in patients after TKA.
Type of Study: Research Article |
Subject:
Knee surgery
Received: 2022/11/2 | Accepted: 2022/12/12 | Published: 2023/02/1
Received: 2022/11/2 | Accepted: 2022/12/12 | Published: 2023/02/1
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
